title: A revolution in the treatment of non-Hodgkin's lymphoma.
abstract: The use of monoclonal antibodies (MoAbs) for immunotherapy and radioimmunotherapy has ushered in a new era in the treatment of non-Hodgkin's lymphoma.
authors.affiliation: University of California, Davis, School of Medicine, Department of Internal Medicine, Sacramento 95618, USA.
authors.forename: G L
authors.initials: GL
authors.lastname: DeNardo
authors.forename: R T
authors.initials: RT
authors.lastname: O'Donnell
authors.forename: R K
authors.initials: RK
authors.lastname: Oldham
authors.forename: S J
authors.initials: SJ
authors.lastname: DeNardo
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D016499:Radioimmunotherapy
chemical_list: D000911:Antibodies, Monoclonal